Skip to content
Open access

SARS-CoV-2 Exposure Elicits a Strong Mucosal Antibody Response That May Facilitate Quicker Mucosal Viral Clearance

Sep 2026 · Viruses · Vol 18 · 0 citations · 53 references
Medicine

TL;DR

A potential functional role for SOF anti-SARS-CoV-2 spike antibodies in clearing SARS-CoV-2 from the oral mucosa is suggested, suggesting a more rapid decline in SARS-CoV-2 burden.

Abstract

The entry of SARS-CoV-2 via the mucosal surfaces of the upper respiratory tract, including the oral cavity, may be influenced by innate and adaptive immunity. We aimed to determine whether antibodies in secretions might influence the SARS-CoV-2 burden and thus the severity of infection. Blood and stimulated oral fluid (SOF) samples were collected at recruitment (d0) from 173 participants and sequentially at d14, d30 and d90 from 52 participants. Anti-SARS-CoV-2 spike antibodies of the IgG, IgA and SIgA isotypes were detected by ELISA. SARS-CoV-2 RNA copies were quantified by RT-PCR. SARS-CoV-2 RNA copies became negative by d14 in most subjects. At d14, 5/18 SOF samples continued to be RT-PCR-positive. Serum/SOF IgG antibodies were detected in all patients; IgG/IgA/SIgA antibodies increased by d14 and decreased by d90. At d0 and d14, SOF RNA copies were negatively correlated with SOF/serum IgG and with SOF IgA/SIgA antibodies. Higher SOF antibodies were significantly associated with a more rapid decline in SARS-CoV-2 burden. SARS-CoV-2 RNA copies and spike-specific antibodies showed differential trends during the major and minor COVID-19 waves in India. Avidity indices for SOF IgG/IgA antibodies declined by d90. Taken together, our data suggest a potential functional role for SOF anti-SARS-CoV-2 spike antibodies in clearing SARS-CoV-2 from the oral mucosa.

Read PDF

Similar papers

Open access Aug 2026

Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant.

It is shown that a Wuhan-lineage-based multi-antigen VLP vaccine can provide cross-protection against an antigenically divergent SARS-CoV-2 variant that is not fully explained by detectable serum neutralizing activity alone, suggesting the importance of integrated immune responses involving humoral, cellular, and local...

Seung-Ji Kim, Howon Kim, Seung-Eun Son et al. · 0 citations
Open access Aug 2026

Early HHV-6 IgG and IgA responses during acute SARS-CoV-2 infection in relation to long COVID: a multicohort observational study

Early herpesvirus-directed antibody responses following SARS-CoV-2 infection exhibit distinct virus- and isotype-specific patterns associated with long COVID, suggesting that heterogeneity in long COVID may be linked to differential herpesvirus-directed humoural immune responses that emerge early after infection.

Ananya Choudhury, M. Burry, W. Kwon et al. · 0 citations
Review Open access Sep 2026

Measurement of binding antibodies to SARS-CoV-2 variants elicited by natural infection and COVID-19 vaccines in a sub-Saharan African population

These findings provide rare data on variant-specific vaccine-elicited antibody binding responses in West and Central African populations with distinct demographic, epidemiologic, and immunologic background.

E. Lusamaki, Ana M. Ortega-Villa, Daouda Camara et al. · 0 citations
Open access Aug 2026

Antibody-mediated SARS-CoV-2 entry and conformational regulation

There is a connection between RBD conformational regulation, epitope, and AME for antibodies targeting SARS-CoV-2, which improves understanding of the AME mechanism and how to inhibit AME for SARS-CoV-2, which has potential applications in the continued development of safe and effective vaccines and therapeutics for CO...

Casey L Kiyohara, Sheamin Kim, W. Thomas · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.